Amneal Pharmaceuticals Inc (AMRX)
6.36
-0.06
(-0.93%)
USD |
NASDAQ |
Jun 28, 16:00
6.36
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Revenue (Annual): 2.394B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 2.394B |
December 31, 2022 | 2.212B |
December 31, 2021 | 2.094B |
December 31, 2020 | 1.993B |
Date | Value |
---|---|
December 31, 2019 | 1.626B |
December 31, 2018 | 1.663B |
December 31, 2017 | 1.034B |
December 31, 2016 | 1.018B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.626B
Minimum
2019
2.394B
Maximum
2023
2.064B
Average
2.094B
Median
2021
Revenue (Annual) Benchmarks
Fate Therapeutics Inc | 63.53M |
Ocular Therapeutix Inc | 58.44M |
Editas Medicine Inc | 78.12M |
AnaptysBio Inc | 17.16M |
AEON Biopharma Inc | -- |